Additionally, defects in another DDR molecule, BRCA1 (a mutation or reduced expression of the BRCA1 protein), via epigenetic downregulation, are associated with breast cancer stem cells in a mouse model and in human cancers11, 12 and result in aggressive clinical course of breast and ovarian tumor13. Here, BRCA1 is linked to breast cancer.